Early Use of Inhaled Nitric Oxide in Preterm Infants: Is there a Rationale for Selective Approach?

BACKGROUND: Inhaled nitric oxide (iNO) is being increasingly used in preterm infants < 34 weeks with hypoxemic respiratory failure (HRF) and/or pulmonary hypertension (PH). OBJECTIVE: To evaluate the risk factors, survival characteristics, and lung histopathology in preterm infants with PH/HRF. M...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Am J Perinatol
Päätekijät: Chandrasekharan, Praveen, Kozielski, Rafal, Kumar, Vasantha H.S., Rawat, Munmun, Manja, Veena, Ma, Changxing, Lakshminrusimha, Satyan
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2016
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5572579/
https://ncbi.nlm.nih.gov/pubmed/27627792
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1055/s-0036-1592346
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia